These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16595828)

  • 1. Influence of sampling and storage conditions on B-type natriuretic peptide immunoreactivity for 3 automated assays.
    Gruson D; Rousseau MF; de Coninck V; Ahn SA; Ketelslegers JM
    Clin Chem; 2006 Apr; 52(4):766-7. PubMed ID: 16595828
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure.
    Wu AH; Smith A; Apple FS
    Am J Cardiol; 2004 Jun; 93(12):1562-3. PubMed ID: 15194039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of different sample types and stability after blood collection of N-terminal pro-B-type natriuretic peptide as measured with Roche Elecsys system.
    van der Merwe DE; Henley R; Lane G; Field R; Frenneaux M; Dunstan F; McDowell I
    Clin Chem; 2004 Apr; 50(4):779-80. PubMed ID: 15044344
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease.
    Rutten FH; Cramer MJ; Zuithoff NP; Lammers JW; Verweij W; Grobbee DE; Hoes AW
    Eur J Heart Fail; 2007; 9(6-7):651-9. PubMed ID: 17347037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodical approach to collecting and preserving plasma samples containing B-type natriuretic peptide.
    Hazuková R; Pleskot M; Strítecká H
    Eur J Heart Fail; 2007 Feb; 9(2):216-7; author reply 215. PubMed ID: 17254845
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of sample type and delayed separation from cells on the measurement of B-type natriuretic peptide with the Architect system.
    Janssen MJ; Velmans MH; Willemse N
    Clin Chem Lab Med; 2013 Oct; 51(10):e235-7. PubMed ID: 23645124
    [No Abstract]   [Full Text] [Related]  

  • 9. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.
    Wu AH; Packer M; Smith A; Bijou R; Fink D; Mair J; Wallentin L; Johnston N; Feldcamp CS; Haverstick DM; Ahnadi CE; Grant A; Despres N; Bluestein B; Ghani F
    Clin Chem; 2004 May; 50(5):867-73. PubMed ID: 15010423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
    Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chem; 2004 Jun; 50(6):1104-6. PubMed ID: 15161739
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide.
    Prontera C; Storti S; Emdin M; Passino C; Zyw L; Zucchelli GC; Clerico A
    Clin Chem; 2005 Jul; 51(7):1274-6. PubMed ID: 15976111
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH
    Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement and importance of plasma brain natriuretic peptide and related peptides.
    Sagnella GA
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):83-93. PubMed ID: 11269760
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure.
    Kelder JC; Cramer MJ; Verweij WM; Grobbee DE; Hoes AW
    J Card Fail; 2011 Sep; 17(9):729-34. PubMed ID: 21872142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
    Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
    Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spuriously high B-type natriuretic peptide level caused by human antimouse antibodies.
    Pan XH; Zhang SZ; Chen HQ; Xiang MX; Wang JA
    Ann Intern Med; 2011 Sep; 155(6):407-8. PubMed ID: 21930867
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives.
    Bettencourt PM
    Heart; 2005 Nov; 91(11):1489-94. PubMed ID: 16230457
    [No Abstract]   [Full Text] [Related]  

  • 20. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.